Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B

Table 4 Sequential changes and comparisons of serum ferritin levels (μg/L) at different time points during lamivudine treatment in patients with normalized serum ALT and those with abnormal ALT at end of treatment

Group	Baseline	Months after treatment
		3	6	12
HBV DNA ( - ) group (n = 19)	198.40 ± 161.58	139.39 ± 111.3	112.35 ± 57.51	99.19 ± 60.52
HBV DNA ( + ) group (n = 19)	220.22 ± 136.72	173.56 ± 109.68	140.37 ± 86.07	155.21 ± 98.94
P values	0.656	0.347	0.266	0.048